Implantable lead functional status monitor and method

• US 20020120307A1
• Filed: 12/31/2001
• Published: 08/29/2002
• Est. Priority Date: 01/19/2000
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: McVenes, Rick D., Wahlstrand, John D., Peck, Bradley C., Jorgenson, David J., Trautmann, Charles D., Starkson, Ross O.
• Granted Patent: US 6,721,600 B2
• Time in Patent Office: Days
• US Class Current: 607/27
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.

Claims

1. A lead status monitor system comprising:

an implantable medical device;

a lead electrically coupled to said implantable medical device; and

a software implemented in the processor of said implantable medical device able to perform weighted sum analysis to display messages relating to said lead status.

2. The system of claim 1 wherein said weighted sum analysis is based on a lead impedance measurement.

3. The system of claim 1 wherein a said weighted sum is based on a non-physiologic sensed event.

4. The system of claim 1 wherein a said weighted sum is based on percent time mode switch.

5. The system of claim 1 wherein a said weighted sum is based on capture management thresholds.

6. The system of claim 1 wherein a said weighted sum is based on sensing assurance settings.

7. The system of claim 1 wherein a said weighted sum is based on reversion pace counts.

8. The system of claim 1 wherein a said weighted sum is based on refractory sense counts.

9. The system of claim 1 wherein a said weighted sum is based on high rate episode counts.

10. The system of claim 1 wherein a said weighted sum is based on time from implant.

11. The system of claim 1 wherein said messages relate to lead insulation issues.

12. The system of claim 1 wherein said messages relate to biological lead interface issues.

13. The system of claim 1 wherein said messages relate to lead indicator/connector issues.

14. The system of claim 13 wherein said message relating to lead conductor/connector issues is based on a lead impedance measurement of a 200% increase in impedance from a stable reference measurement.

15. The system of claim 11 wherein said message relating to lead insulation issues is based on a lead impedance measurement of a 50% decrease in impedance from a stable reference measurement.